[Pharmacokinetic interaction of drugs with cardiac glycosides; which are clinically important?].
Hooymans
P M
PM
Merkus
F W
FW
D000863:Antacids / Q000494:pharmacology; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D000890:Anti-Infective Agents / Q000494:pharmacology; D000925:Anticoagulants / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002301:Cardiac Glycosides / Q000378:metabolism*; D004232:Diuretics / Q000494:pharmacology; D004347:Drug Interactions; D006801:Humans; D014665:Vasodilator Agents / Q000494:pharmacology
D000863:Antacids; D014151:Anti-Anxiety Agents; D000889:Anti-Arrhythmia Agents; D000890:Anti-Infective Agents; D000925:Anticoagulants; D000927:Anticonvulsants; D000970:Antineoplastic Agents; D002121:Calcium Channel Blockers; D002301:Cardiac Glycosides; D004232:Diuretics; D014665:Vasodilator Agents
Farmacokinetische interacties van geneesmiddelen met hartglycosiden; welke zijn van klinisch belang?